Compare · STAA vs WRBY
STAA vs WRBY
Side-by-side comparison of STAAR Surgical Company (STAA) and Warby Parker Inc. (WRBY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both STAA and WRBY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- WRBY is the larger of the two at $3.56B, about 2.6x STAA ($1.38B).
- Over the past year, STAA is up 62.6% and WRBY is up 26.8% - STAA leads by 35.8 points.
- Both names hit the wire about 9 times in the past 4 weeks.
- Both have 25 recent analyst ratings on file.
- Company
- STAAR Surgical Company
- Warby Parker Inc.
- Price
- $28.13+1.39%
- $29.15+0.28%
- Market cap
- $1.38B
- $3.56B
- 1M return
- -4.12%
- +16.41%
- 1Y return
- +62.57%
- +26.79%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 9
- 9
- Recent ratings
- 25
- 25
STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Warby Parker Inc.
Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Latest STAA
- SEC Form S-8 filed by STAAR Surgical Company
- SEC Form 4 filed by Director Wang Christopher Min Fang
- SEC Form 4 filed by Director Lebuhn Richard T.
- SEC Form 4 filed by Director Bradsher Neal C
- Director Butcher Arthur C converted options into 5,341 shares, increasing direct ownership by 127% to 9,549 units (SEC Form 4)
- SEC Form 4 filed by Director Zhou Lilian Yansheng
- STAAR Surgical Company filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Silverman Lou converted options into 10,683 shares, increasing direct ownership by 2,249% to 11,158 units (SEC Form 4)
- Director Jiang Wei converted options into 10,683 shares, increasing direct ownership by 16% to 77,127 units (SEC Form 4)
- Director Zhou Lilian Yansheng was granted 3,530 shares, increasing direct ownership by 77% to 8,101 units (SEC Form 4)
Latest WRBY
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 9,200 shares and sold $275,908 worth of shares (9,200 units at $29.99) as part of a pre-agreed trading plan (SEC Form 4)
- Co-Chief Executive Officer Gilboa David Abraham converted options into 54,347 shares and sold $1,621,714 worth of shares (54,347 units at $29.84) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Warby Parker Inc.
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 189,320 shares and sold $6,445,120 worth of shares (217,667 units at $29.61) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)
- Co-Chief Executive Officer Gilboa David Abraham converted options into 213,746 shares and sold $7,191,541 worth of shares (242,221 units at $29.69) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)
- Director Raider Jeffrey Jacob sold $668,700 worth of shares (22,500 units at $29.72) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 435,201 units (SEC Form 4)
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 36,300 shares and sold $1,090,452 worth of shares (36,300 units at $30.04) as part of a pre-agreed trading plan (SEC Form 4)
- BofA Securities initiated coverage on Warby Parker with a new price target
- SEC Form 4 filed by Co-Chief Executive Officer Blumenthal Neil Harris
- Director Briggs Teresa sold $129,683 worth of shares (5,000 units at $25.94) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 48,883 units (SEC Form 4)